B. Braun Avitum - Centro de Atención Renal
Massamagrell, Valencia, 46130, Spain
NCT Number: NCT06660160
People with chronic kidney disease (CKD) undergoing hemodialysis (HD) experience muscular complications, such as sarcopenia, which worsen their functional capacity and increase mortality. Exercise programs during HD are an effective strategy to combat sedentary behavior, and implementing them through innovative technologies could facilitate their adoption in clinics, benefiting more patients. Therefore, the study's objectives are to assess the feasibility and safety of a group exercise program supported by audiovisual media conducted during HD sessions. Additionally, it will analyze factors influencing adherence, identify potential causes for interruptions or failure to perform the prescribed exercise, and evaluate the risk and prevalence of sarcopenia, its association with low muscle strength, poor muscle quality, and physical inactivity.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Interventional
Not applicable
Massamagrell, Valencia, 46130, Spain
A 4-week randomized experimental study will be conducted, using an exercise protocol during HD, broadcast simultaneously on television. The frequency of exercise completion, reasons for non-completion, adverse events, as well as sarcopenia, muscle strength, muscle characteristics through ultrasound and electrical bioimpedance, and physical activity levels will be evaluated.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The intervention group will perform the group exercise protocol during HD sessions. The videos with the exercises will be broadcast on all televisions simultaneously, so that the volunteers perform the exercises along with the person in the video.
Exercises will be performed 3 times per week over a 4-week period, for a total of 12 planned exercise sessions.
Other names: Exercise, Exercise training, Exercise training during hemodialysis, Physiotherapy, Online exercise training
Time frame: From start to finish of intervention (4 weeks)
Feasibility will be assessed through adherence rate (number of sessiones performed out of sessions offered).
Time frame: From start to finish of intervention (4 weeks)
Adverse events of the exercise during the study (number of adverse events)
Time frame: It will be applied before and after the 4 weeks of intervention.
The risk of sarcopenia will be evaluated using the SARC-F (Strength, Assistance with walking, Rising from a chair, Climbing stairs and Falls )questionnaire. Score ranges from 0 a 10, higher scores mean higher risc of sarcopenia.
Time frame: It will be applied before and after the 4 weeks of intervention
Handgrip strength
Time frame: It will be applied before and after the 4 weeks of intervention.
Lower limb muscle strength assessments via digital manual dynamometry will be performed during HD using the MMT Lafayette Instrument Company hand dynamometer.
Time frame: It will be applied before and after the 4 weeks of intervention
The quantity and quality of muscle mass will be evaluated by the cross-sectional area of the rectus femoris muscle, measured by muscle ultrasound.
Time frame: It will be applied before and after the 4 weeks of intervention.
Body composition and appendicular skeletal muscle mass will also be measured by multi-frequency bioelectrical impedance analysis (BIA),
Time frame: It will be applied before and after the 4 weeks of intervention.
The level of physical activity will be evaluated using the HAP questionnaire (Average Activity Score AAS).
Cardenal Herrera University
Other
Evaluating The Feasibility And Safety Of A Group Exercise Program Supported By Audiovisual Media During Hemodialysis (GrExID)
Acronym: GrExID
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07545629
Chronic Disease, Chronic Kidney Disease, Stage IV (Severe)
Wuhu, Anhui, China
View Trial DetailsNCT07212972
Avitaminosis, Bone Diseases
Kayseri, Turkey (Türkiye)
View Trial DetailsNCT06981585
Behavior, Chronic Disease
Izmir, Turkey (Türkiye)
View Trial DetailsNCT04522115
Behavior, Body Weight
Cairo, Egypt
View Trial Details